Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1977-09-27
1980-04-08
Padgett, Benjamin R.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
260112B, 26023955C, 2603971, 424 12, G01N 3316, A61K 4300, C07D47100, C07J 4100
Patent
active
041972864
ABSTRACT:
An anti-testosterone serum is provided which is highly selective to the measurement of testosterone using radioimmunossay techniques in both male and female plasma without resorting to chromatography even though the plasma may have a high 5.alpha.-dihydrotestosterone content. In addition, the high progesterone concentration normally present in female plasma has no effect on the assay of this plasma. The preferred hapten for producing the serum is 17.beta., 19-dihydroxyandrost-4-en-3-one 19-carboxymethyl ether although related compounds as disclosed herein are also useful.
REFERENCES:
patent: 4031117 (1977-06-01), Rao
patent: 4085202 (1978-04-01), Rao
Ed. Gupta, Radio Immuno Assay of Steroid Hormones, Verlag Chemie, Weinheim, 1975, pp. 84-90.
Hyer W. F.
Nucker Christine M.
Padgett Benjamin R.
Southwest Research Institute
LandOfFree
Testosterone derivatives and assay method does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Testosterone derivatives and assay method, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Testosterone derivatives and assay method will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-973558